[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353627-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353627-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","tumor-microbiome-transcriptome-crosstalk-identifies-prevotella-as-an-immunotherapeutic-predictor-in-nsclc","Tumor microbiome-transcriptome crosstalk identifies Prevotella as an immunotherapeutic predictor in NSCLC","","The tumor-resident microbiome is critical for shaping the tumor immune microenvironment, yet its links to host transcriptome changes and response to immune checkpoint inhibitors (ICIs) in non–small cell lung cancer (NSCLC) remain unclear. Paired tumor and paracancerous tissues were profiled with 2bRAD-M and bulk RNA sequencing, using conditional mutual information to map microbe–host interactions. Paracancer-resident Prevotella predicted improved prognosis and ICI response, enabling a blood-indicator plus Prevotella model that outperformed PD-L1, without association in EGFR-targeted therapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/tumor-microbiome-transcriptome-crosstalk-identifies-prevotella-as-an-immunotherapeutic-predictor-in-nsclc/353627/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/tumor-microbiome-transcriptome-crosstalk-identifies-prevotella-as-an-immunotherapeutic-predictor-in-nsclc/353627.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s main goal in NSCLC?","Question",{"text":63,"@type":64},"To clarify how tissue-resident microbiota relates to host transcriptomic alterations and to immunotherapy response in NSCLC.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were tumor–microbiome and transcriptome interactions investigated?",{"text":68,"@type":64},"Paired tumor and paracancerous tissue samples were analyzed using 2bRAD-M and bulk RNA sequencing, and intratumoral microbe–host interactions were assessed with a conditional mutual information algorithm.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the significance of paracancer-resident Prevotella?",{"text":72,"@type":64},"Paracancer-resident Prevotella was independently associated with improved prognosis and better ICI response across local cohorts and public datasets, forming a diagnostic model that outperformed PD-L1.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353627,1790175066,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Theranostics 2026, Vol. 16, Issue 7  \nIvyspring  \nInternational Publisher  \n3426  \nTheranostics  \n2026; 16(7): 3426-3446. doi: 10.7150/thno.126091  \nResearch Paper  \nTumor microbiome-transcriptome crosstalk identifies Prevotella as an immunotherapeutic predictor in NSCLC  \nNa Wang1*, Lifang Ma2*, Yugang Huang3*, Xionghui Zhou4*, Yuan Rong3, Fei Long3, Wanbo Qiu4, Si Wu3, Yue Hu3, Xin He3, Jiurong He3, Sufang Tian5􀀍, Weidong Hu6􀀍, Chunhui Yuan7􀀍, Fubing Wang8,9,10􀀍  \n1. Department of Pathology, Renmin Hospital of Wuhan University, Wuhan 430060, China.  \n2. Department of Clinical Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.  \n3. Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.  \n4. College of Informatics, Huazhong Agricultural University, Wuhan 430070, China.  \n5. Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.  \n6. Department of Thoracic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.  \n7. Department of Laboratory Medicine, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430016, China.  \n8. Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan 430060, China.  \n9. Center for Single-Cell Omics and Tumor Liquid Biopsy, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.  \n10. Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan 430071, China.  \n*These authors have contributed equally to this work  \n􀀍 Corresponding authors: Sufang Tian: [sftian@whu.edu.cn](sftian@whu.edu.cn); Weidong Hu: [huwd@whu.edu.cn](huwd@whu.edu.cn); Chunhui Yuan: [chunhuii.yuen@whu.edu.cn](chunhuii.yuen@whu.edu.cn); Fubing Wang: [wangfubing@znhospital.cn](wangfubing@znhospital.cn).  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [https://ivyspring.com/terms](https://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2025.09.30; Accepted: 2025.11.18; Published: 2026.01.01  \nAbstract  \n\n| Background: The tumor-resident microbiome plays a pivotal role in shaping the tumor immune microenvironment; however, its relationship with the host transcriptome and the response to immune checkpoint inhibitors (ICIs) remains largely uncharacterized in non–small cell lung cancer (NSCLC). This study aimed to elucidate the relationship between tissue-resident microbiota, host transcriptomic alterations, and immunotherapy response in NSCLC.\u003Cbr>Methods: Paired tumor (T) and paracancerous tissue (PT) samples from patients with NSCLC were analyzed using 2bRAD-M and bulk RNA sequencing to generate comprehensive microbiome and transcriptome profiles. The conditional mutual information algorithm was employed to systematically investigate intratumoral microbe–host interactions. Associations between key microbes and patient prognosis, ICI response, and response to epidermal growth factor receptor (EGFR)–targeted therapy were assessed across four independent local clinical cohorts.\u003Cbr>Results: Higher microbial richness, α-diversity, and β-diversity were observed in PT samples than in T samples. Specifically, PT-resident Bradyrhizobium and Prevotella were identified as key bacterial taxa significantly associated with immune cell populations, including CD8+ T cells, natural killer cells, and activated dendritic cells. Among these, PT-resident Prevotella, but not Bradyrhizobium, was independently associated with improved prognosis of patients with NSCLC and ICI response in both local clinical sets and public datasets. Furthermore, a combined diagnostic model integrating PT-resident Prevotella abundance with routine clinical blood indicators demonstrated","cbCaigTF78gHdJ40","https://ap.wps.com/l/cbCaigTF78gHdJ40","pdf",53098866,21,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What was the study’s main goal in NSCLC?\",\"answer\":\"To clarify how tissue-resident microbiota relates to host transcriptomic alterations and to immunotherapy response in NSCLC.\"},{\"question\":\"How were tumor–microbiome and transcriptome interactions investigated?\",\"answer\":\"Paired tumor and paracancerous tissue samples were analyzed using 2bRAD-M and bulk RNA sequencing, and intratumoral microbe–host interactions were assessed with a conditional mutual information algorithm.\"},{\"question\":\"What is the significance of paracancer-resident Prevotella?\",\"answer\":\"Paracancer-resident Prevotella was independently associated with improved prognosis and better ICI response across local cohorts and public datasets, forming a diagnostic model that outperformed PD-L1.\"}]","Tumor microbiome-transcriptome crosstalk identifies Prevotella as an immunotherapeutic predictor in NSCLC | PDF",1790106436,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97694b83e680e646abccff2519ab1de5.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2268526ad05d3977f304a9dff2cb6ccd.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/782856732af1db939fe117c03897b0bc.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c6d0990729474842275eeebbdb333d2.webp",980,1268]